Impact of Aging on Lung Tumorigenesis 2021 Emerging Leader Award Tuomas Tammela, MD, PhD, Memorial Sloan Kettering Cancer Center Read More
Cellular and Molecular Drivers of Obesity-Associated Breast Cancer 2021 Emerging Leader Award Paul Cohen, MD, PhD, Rockefeller University Read More
Targeting Oncogenic Proteoforms Using Tyrosine-Reactive Chemistry 2021 Emerging Leader Award Ku-Lung (Ken) Hsu, PhD, University of Virginia Read More
Deciphering Organellar Oxidative Metabolism in Kras-Driven Cancers 2021 Emerging Leader Award Kıvanç Birsoy, PhD, Rockefeller University Read More
In vivo Forward Genetic Screens to Identify Immunotherapy Resistance Mechanisms and Synergistic Treatment Combinations for Cancer 2021 Emerging Leader Award Hao Zhu, MD, Children’s Medical Center Research Institute at UT Southwestern Read More
Identifying and Targeting 3D Enhancer Hubs that Maintain Cancer Stem Cell Programs 2021 Emerging Leader Award Effie Apostolou, PhD, Weill Cornell Medicine Read More
Causes and Consequences of Rapid Cancer Cell Adaptation to MAPK Pathway Inhibitors 2021 Emerging Leader Award Sabrina Spencer, PhD, University of Colorado Boulder Read More
Decoding the Regulatory Network of Tumor Progression in Childhood Ependymoma ASPIRE Award (2021-Present) Pablo Gonzalez Cámara, PhD, University of Pennsylvania Read More
Engineering TILs to Utilize Kynurenine as an Essential Nutrient for Survival in the Tumor Microenvironment In Partnership with Emerson Collective (2021-Present) David Hockenbery, MD, Fred Hutchinson Cancer Research Center Read More
Evolution of Megakaryocyte Abnormalities in the Progression of Primary Myelofibrosis The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present) Johanna Melo-Cardenas, PhD, St. Jude Children’s Research Hospital Read More
Cell Morphological Modulation of Oncogenic RAS Signaling Damon Runyon - Mark Foundation Postdoctoral Fellow (2021-Present) Gabriel Muhire Gihana, PhD, University of Texas Southwestern Medical Center Read More
Deciphering Immune Cell Heterogeneity and Transcriptomic Changes Associated with CRS Development and Severity in CAR-T Cell Treated Patients The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present) Sylvain Simon, PhD, Fred Hutchinson Cancer Research Center Read More
Evaluating a Novel Collaboration Between NOTCH1 and MLL1 for Improved Targeted Treatments in T-ALL The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present) Therese Vu, PhD, University of Colorado Denver Read More
Characterize the Role of Non-Vesicular Cholesterol Transport in CD8+ T Cell Function Damon Runyon - Mark Foundation Postdoctoral Fellow (2021-Present) Yajing Gao, PhD, University of California, Los Angeles Read More
Induced Proximity for Destabilization of Core Regulatory Factors in Alveolar Rhabdomyosarcoma ASPIRE Award (2020-Present) Benjamin Stanton, PhD (Principal), Nationwide Children's Hospital and Jun Qi, PhD, Dana-Farber Cancer Institute Read More
Molecular Mechanisms of Tumor Progression and Plasticity in Bladder Cancer Endeavor Award (2020-Present) Cory Abate-Shen, PhD, and Michael Shen, PhD, Columbia University - Principal Investigators Read More
Evoking Immune Response Using Phosphorylation-Inducing Chimeric Small Molecules ASPIRE Award (2020-Present) Amit Choudhary, PhD, Harvard Medical School Read More
